Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

Australia clears Chemist Warehouse-Sigma Healthcare $5.8 billion deal

By Sameer Manekar and Rishav Chatterjee

(Reuters) – The Australian competition regulator, on Thursday, cleared privately owned pharmacy chain Chemist Warehouse’s reverse takeover of Sigma Healthcare, paving the way to create an A$8.8 billion ($5.78 billion) entity after a year-long wait.

Sigma’s stock surged almost 40%, the most on the Australian benchmark index, to hit a record high.

Chemist Warehouse had said roughly a year back it would buy Sigma for stock and A$700 million in cash, giving it a roughly 85% stake in the merged entity and a backdoor way to list on the stock exchange at a time when global capital markets were in the doldrums.

But the deal — creating a company supplying around 1,000 Sigma-aligned pharmacies and owning 600 Chemist Warehouse outlets — has been under the Australian Competition and Consumer Commission’s (ACCC) scrutiny and was cleared after the companies made concessions to alleviate competition concerns.

The ACCC said the proposed deal was unlikely to substantially lessen competition subject to Sigma allowing franchises to opt out of their agreements without penalties to make it easier for a pharmacy to switch networks.

“The ACCC’s analysis found that the proposed merger is unlikely to substantially lessen competition nationally or locally because other pharmacies and non-pharmacy retailers will continue to compete to the same extent they compete now,” Chair Gina Cass-Gottlieb said.

Brokerage Jefferies said investors will get access to a standout retail franchise in the healthcare sector once the deal closes.

Despite the ACCC’s clearance, the deal faces criticism from rival Ebos Australia and a powerful industry group in Canberra called Pharmacy Guild.

“The ACCC will need to carefully monitor the merger and its impact on patients,” said a spokesperson for the Guild.

“Market consolidation in health services leads to non-competitive duopolies, an unequal distribution of doctors and a reduction in smaller businesses better equipped to provide local and personalised health services to their communities.”

Ebos did not immediately respond to a Reuters request for comment. ($1 = 1.5129 Australian dollars)

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com